Buy Granules India, target Rs 160.0 : Nirmal Bang Securities
Buy Granules India Ltd. at a price target of Rs 160.0 and a stop loss at Rs 149.0 from entry point
Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of ₹ 3377.94 Cr.) operating in Pharmaceuticals and health care sector.
Granules India Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed ₹ 1358.42 Cr to Sales Value (99.93 % of Total Sales) and Scrap which contributed ₹ .86 Cr to Sales Value (0.06 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-03-2017, the company has reported a Consolidated sales of ₹ 355.25 Cr., down -1.11% from last quarter Sales of ₹ 359.24 Cr. and down -4.57% from last year same quarter Sales of ₹ 372.27 Cr. Company has reported net profit after tax of ₹ 36.28 Cr. in latest quarter. The company’s CEO is Mr.Krishna Prasad Chigurupati. It's Board of Directors include Ms.Chaitanya Tummala, Mr.B Madhusudan Rao, Mr.Stefan Lohle Corredor, Mr.V V S Murthy, Ms.Chaitanya Tummala, Dr.Krishna Murthy Ella, Dr.V V N K V Prasada Raju, Mr.A P Kurian, Mr.Arun Rao Akinepally, Mr.C Parthasarathy, Mr.Harsha Chigurupati, Mr.K B Sankar Rao, Mr.Krishna Prasad Chigurupati, Mr.L S Sarma, Mrs.Uma Devi Chigurupati. Company has its registered office at 2nd Floor, , 3rd Block, , My Home Hub, , Hyderabad, 500081, Andhra Pradesh. Company has Kumar & Giri as its auditors. As on 31-03-2017, the company has a total of 228,702,770 shares outstanding.
Download ET Markets APP